Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$149.30 2.76 (1.82%) as of 4:30 Thu 6/6


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 18.37(B)
Last Volume: 534,229 Avg Vol: 722,453
52 Week Range: $143.31 - $211.65
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,700 98,555 124,204 268,793
Total Sell Value $3,224,546 $16,182,261 $20,937,886 $52,053,725
Total People Sold 1 8 9 10
Total Sell Transactions 1 13 19 36
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 748
  Page 24 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sharp Philip A Director   –       •      –    2012-02-21 4 B $10.75 $99,997 D/D 9,302 9,302 2.39     -
   Reid Laurence SVP, Chief Business Officer   •       –      –    2012-02-21 4 B $10.75 $9,998 D/D 930 11,681 2.74     -
   Greene Barry E President and COO   •       –      –    2012-02-21 4 B $10.75 $19,995 D/D 1,860 4,572 2.74     -
   Maraganore John CEO   •       •      –    2012-02-21 4 B $10.75 $59,996 D/D 5,581 58,503 2.81     -
   Reid Laurence SVP, Chief Business Officer   •       –      –    2012-01-23 4 A $0.00 $0 D/D 10,751 10,751     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2012-01-23 4 A $0.00 $0 D/D 7,847 7,847     -
   Greene Barry E President and COO   •       –      –    2012-01-09 4 AB $8.80 $4,992 D/D 567 2,712     -
   Maraganore John CEO   •       •      –    2012-01-09 4 AB $8.81 $9,995 D/D 1,134 52,922     -
   Greene Barry E President and COO   •       –      –    2011-12-12 4 AB $7.15 $4,995 D/D 699 2,145     -
   Maraganore John CEO   •       •      –    2011-12-12 4 AB $7.15 $9,995 D/D 1,397 51,788     -
   Maraganore John CEO   •       •      –    2011-11-14 4 AB $7.08 $9,997 D/D 1,411 50,391     -
   Greene Barry E President and COO   •       –      –    2011-10-11 4 AB $6.73 $4,996 D/D 742 742     -
   Maraganore John CEO   •       •      –    2011-10-11 4 AB $6.75 $9,989 D/D 1,480 48,980     -
   Mason Michael VP, Finance and TreasurerOffic   •       –      –    2011-02-28 3 IO $0.00 $0 I/I 0 708     -
   Maraganore John CEO   •       •      –    2011-02-23 4 GD $0.00 $0 D/D 2,500 47,500     -
   Koblan Kenneth S Chief Scientific OfficerOffice   •       –      –    2010-12-08 3 IO $0.00 $0 I/I 0 357     -
   Maraganore John CEO   •       •      –    2010-08-17 4 OE $0.48 $23,750 D/D 50,000 50,000     -
   Vincent James L Director   –       •      –    2010-06-18 4 S $15.16 $315,217 D/D (20,767) 0     -
   Vincent James L Director   –       •      –    2010-06-18 4 OE $7.02 $84,942 D/D 12,100 12,100     -
   Vincent James L Director   –       •      –    2010-06-17 4 S $15.70 $20,930 D/D (1,333) 8,667     -
   Vincent James L Director   –       •      –    2010-06-15 4 S $16.00 $480,090 D/D (30,000) 10,000     -
   Vincent James L Director   –       •      –    2010-06-15 4 OE $7.02 $210,600 D/D 30,000 40,000     -
   Vincent James L Director   –       •      –    2010-06-14 4 S $16.05 $287,992 D/D (17,900) 10,000     -
   Vincent James L Director   –       •      –    2010-06-14 4 OE $7.02 $125,658 D/D 17,900 12,900     -
   Vincent James L Director   –       •      –    2010-06-11 4 S $15.95 $239,250 D/D (15,000) 10,000     -
  748 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 24 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us